Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.
Saved in:
| Title: | Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. |
|---|---|
| Authors: | Gonzalez-Cao M; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain mgonzalezcao@oncorosell.com., Sisteré-Oró M; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Moran T; Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain., Reguart N; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain., Cabezon R; Immunology Department, Hospital Clinic de Barcelona, FRCB-IDIBAPS, UB, Barcelona, Spain., Aguilar Hernández A; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Roman R; Instituto Oncologico Dr Rosell and PangaeaOncology Lab, Dexeus University Hospital, Barcelona, Spain., Molina-Vila MA; Instituto Oncologico Dr Rosell and PangaeaOncology Lab, Dexeus University Hospital, Barcelona, Spain., Birgin K; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Domenjo-Vila E; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Piqué G; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Lozano M; Apheresis Unit, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain., Charry P; Apheresis Unit, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain., Reyes R; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.; Instituto Oncologico Dr Rosell, Quirón Teknon Hospital, Barcelona, Spain., Moya I; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.; Instituto Oncologico Dr Rosell, Hospital Universitari General de Catalunya, Sant Cugat, Spain., Cirera L; Instituto Oncologico Dr Rosell, Hospital Universitari Sagrat Cor, Barcelona, Spain., Esparre C; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Drozdowskyj A; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Martínez Pérez E; Instituto Oncologico Dr Rosell and PangaeaOncology Lab, Dexeus University Hospital, Barcelona, Spain., Rosell R; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Juan M; Immunology Department, Hospital Clinic de Barcelona, FRCB-IDIBAPS, UB, Barcelona, Spain., Meyerhans A; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; ICREA, Barcelona, Spain., Benitez-Ribas D; Immunology Department, Hospital Clinic de Barcelona, FRCB-IDIBAPS, UB, Barcelona, Spain. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jul 24; Vol. 14 (7). Date of Electronic Publication: 2026 Jul 24. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42498486 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gonzalez-Cao+M%22">Gonzalez-Cao M</searchLink>; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain mgonzalezcao@oncorosell.com.<br /><searchLink fieldCode="AU" term="%22Sisteré-Oró+M%22">Sisteré-Oró M</searchLink>; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moran+T%22">Moran T</searchLink>; Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Reguart+N%22">Reguart N</searchLink>; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cabezon+R%22">Cabezon R</searchLink>; Immunology Department, Hospital Clinic de Barcelona, FRCB-IDIBAPS, UB, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Aguilar+Hernández+A%22">Aguilar Hernández A</searchLink>; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Roman+R%22">Roman R</searchLink>; Instituto Oncologico Dr Rosell and PangaeaOncology Lab, Dexeus University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Molina-Vila+MA%22">Molina-Vila MA</searchLink>; Instituto Oncologico Dr Rosell and PangaeaOncology Lab, Dexeus University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Birgin+K%22">Birgin K</searchLink>; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Domenjo-Vila+E%22">Domenjo-Vila E</searchLink>; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Piqué+G%22">Piqué G</searchLink>; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lozano+M%22">Lozano M</searchLink>; Apheresis Unit, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Charry+P%22">Charry P</searchLink>; Apheresis Unit, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Reyes+R%22">Reyes R</searchLink>; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.; Instituto Oncologico Dr Rosell, Quirón Teknon Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moya+I%22">Moya I</searchLink>; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.; Instituto Oncologico Dr Rosell, Hospital Universitari General de Catalunya, Sant Cugat, Spain.<br /><searchLink fieldCode="AU" term="%22Cirera+L%22">Cirera L</searchLink>; Instituto Oncologico Dr Rosell, Hospital Universitari Sagrat Cor, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Esparre+C%22">Esparre C</searchLink>; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Drozdowskyj+A%22">Drozdowskyj A</searchLink>; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez+Pérez+E%22">Martínez Pérez E</searchLink>; Instituto Oncologico Dr Rosell and PangaeaOncology Lab, Dexeus University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rosell+R%22">Rosell R</searchLink>; Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Juan+M%22">Juan M</searchLink>; Immunology Department, Hospital Clinic de Barcelona, FRCB-IDIBAPS, UB, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Meyerhans+A%22">Meyerhans A</searchLink>; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; ICREA, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Benitez-Ribas+D%22">Benitez-Ribas D</searchLink>; Immunology Department, Hospital Clinic de Barcelona, FRCB-IDIBAPS, UB, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2026 Jul 24; Vol. 14 (7). <i>Date of Electronic Publication: </i>2026 Jul 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42498486 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2026-015351 Languages: – Code: eng Text: English Titles: – TitleFull: Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gonzalez-Cao M – PersonEntity: Name: NameFull: Sisteré-Oró M – PersonEntity: Name: NameFull: Moran T – PersonEntity: Name: NameFull: Reguart N – PersonEntity: Name: NameFull: Cabezon R – PersonEntity: Name: NameFull: Aguilar Hernández A – PersonEntity: Name: NameFull: Roman R – PersonEntity: Name: NameFull: Molina-Vila MA – PersonEntity: Name: NameFull: Birgin K – PersonEntity: Name: NameFull: Domenjo-Vila E – PersonEntity: Name: NameFull: Piqué G – PersonEntity: Name: NameFull: Lozano M – PersonEntity: Name: NameFull: Charry P – PersonEntity: Name: NameFull: Reyes R – PersonEntity: Name: NameFull: Moya I – PersonEntity: Name: NameFull: Cirera L – PersonEntity: Name: NameFull: Esparre C – PersonEntity: Name: NameFull: Drozdowskyj A – PersonEntity: Name: NameFull: Martínez Pérez E – PersonEntity: Name: NameFull: Rosell R – PersonEntity: Name: NameFull: Juan M – PersonEntity: Name: NameFull: Meyerhans A – PersonEntity: Name: NameFull: Benitez-Ribas D IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 07 Text: 2026 Jul 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 14 – Type: issue Value: 7 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |